Cargando…
Trajectory of Humoral Responses to Two Doses of ChAdOx1 nCoV-19 Vaccination in Patients Receiving Maintenance Hemodialysis
The ChAdOx1 nCoV-19 (AZD1222) vaccine is one of the most commonly delivered SARS-CoV-2 vaccines worldwide; however, few clinical studies have investigated its immunogenicity in dialysis patients. We prospectively enrolled 123 patients on maintenance hemodialysis at a medical center in Taiwan. All pa...
Autores principales: | Ling, Tsai-Chieh, Chen, Po-Lin, Li, Nan-Yao, Ko, Wen-Chien, Sun, Chien-Yao, Chao, Jo-Yen, Shieh, Chi-Chang, Shen, Ching-Fen, Wu, Jia-Ling, Huang, Teng-Ching, Chao, Chiao-Hsuan, Wang, Jen-Ren, Chang, Yu-Tzu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100369/ https://www.ncbi.nlm.nih.gov/pubmed/36809164 http://dx.doi.org/10.1128/spectrum.03445-22 |
Ejemplares similares
-
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
por: Chang, Jer-Hwa, et al.
Publicado: (2022) -
Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination
por: Shen, Ching-Fen, et al.
Publicado: (2022) -
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
por: Sheng, Wang-Huei, et al.
Publicado: (2022) -
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis
por: Hsiao, Shih-Hsin, et al.
Publicado: (2023) -
Safety of ChAdOx1 nCoV-19 vaccination in patients with end-stage renal disease on hemodialysis
por: Yang, I-Ning, et al.
Publicado: (2022)